Seeking Alpha

Biotech Analysis Central Model 10+ Portfolio Pick #9 Immunic; Phase 2 CALLIPER Data PMS, Possible Phase 3 Path Forward Vidofludimus Calcium, RMS ENSURE Studies Completed 2026 ...

The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #9 is a biotech by the name of Immunic (IMUX). The reason why I believe that it is important to go over ...
Seeking Alpha

Biotech Analysis Central Model 10+ Portfolio Old Pick#4 Cardiff Oncology; Positive Onvansertib Data RAS Mutant mCRC, Additional Data From Same Study 1st Half 2025 And Catalysts

The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Old Pick #4 is a biotech by the name of Cardiff Oncology (CRDF). The reason why I wanted to go over this ...